Common Contracts
2 similar License and Research Agreement contracts by Kite Pharma, Inc.
EX-10.30 8 kite-ex1030_304.htm EX-10.30 License and research AGREEMENTLicense and Research Agreement • May 5th, 2020 • New York
This License and Research Agreement (the “Agreement”) is effective as of October 26, 2015 (the “Effective Date”) by and between Alpine Immune Sciences, Inc., a Delaware corporation located at 600 Stewart Street, Suite 1503, Seattle, WA 98101 (“Alpine”), and Kite Pharma, Inc., a Delaware corporation located at 2225 Colorado Avenue, Santa Monica, CA 90404 (“Kite”). Alpine and Kite are referred to individually as a “Party” and collectively as the “Parties”.
License and research AGREEMENTLicense and Research Agreement • February 29th, 2016 • Kite Pharma, Inc. • Biological products, (no disgnostic substances) • New York
If any milestone event is achieved for a Licensed Product before any of the preceding milestone events are achieved for such Licensed Product, then all the milestone payments for such unachieved preceding milestone events will be due and payable with the milestone payment for the milestone event that was achieved. For example, if Regulatory Approval for a Licensed Product is achieved from a […***…] without the need to conduct a […***…], then the milestone payment of $[…***…] would be payable along with the milestone payment of $[…***…] for such Licensed Product.
